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High resolution yttrium-90 (90Y) imaging of post-radioembolization microsphere biodistri-
bution may be achieved by conventional positron emission tomography with integrated
computed tomography (PET/CT) scanners that have time-of-flight capability. However,
reconstructed 90Y PET/CT images have high background noise, making non-target activity
detection technically challenging.This educational article describes our image assessment
technique for non-target activity detection by 90Y PET/CT, which qualitatively overcomes the
problem of background noise. We present selected case examples of non-target activity
in untargeted liver, stomach, gallbladder, chest wall, and kidney, supported by angiog-
raphy and 90Y bremsstrahlung single-photon emission computed tomography with inte-
grated computed tomography (SPECT/CT) or technetium-99m macroaggregated albumin
SPECT/CT.
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INTRODUCTION
Radioembolization (RE) is brachytherapy by arterially injected
yttrium-90 (90Y) microspheres for the treatment of malignancies.
Coincidence imaging of 90Y is possible because of a minor decay
branch to the O+ first excited state of zirconium-90 leading to
low abundance internal pair production (1–3). Today, high reso-
lution 90Y imaging of post-RE microsphere biodistribution may
be achieved by conventional positron emission tomography with
integrated computed tomography (PET/CT) scanners that have
time-of-flight capability (1). However, the optimum image acqui-
sition and reconstruction protocols are still the subject of on-going
research across a wide range of scanner types.
For qualitative diagnostic reporting of 90Y PET/CT, two aspects
should always be addressed, i.e., the biodistribution of target
and non-target activity. The presence of non-target activity may
have clinical implications for radiomicrosphere toxicity and is as
important as target activity detection. However, non-target activ-
ity detection by 90Y PET/CT is technically challenging. Today’s
time-of-flight PET/CT scanners use lutetium-based scintillation
crystals, which have intrinsic background activity due to naturally
occurring lutetium-176. The combination of intrinsic background
activity and a very low 90Y positron fraction results in high levels
of noise in reconstructed 90Y PET/CT images, which at the outset,
seem uninterpretable.
Recently, we developed an image assessment technique for
non-target activity detection by 90Y PET/CT, which qualitatively
overcomes the problem of background noise. This is an edu-
cational article highlighting the basic principles of non-target
activity detection by 90Y PET/CT. For technical illustration,
we have selected six case examples to present, which include
the untargeted liver, stomach, gallbladder, chest wall, and
kidney.
90Y PET IMAGING PROTOCOL
Our imaging protocols for 90Y PET/CT, 90Y bremsstrahlung
SPECT/CT, and 99mTc MAA SPECT/CT have been described in
detail elsewhere (4–6). Briefly, for 90Y PET, our scanner is the
GE Discovery 690 PET/CT (General Electric Medical Systems,
Milwaukee, WI, USA) with cerium-activated lutetium–yttrium–
oxyorthosilicate (LYSO) crystals; positron fraction 3.186× 10−5;
half-life 64.1 h; 15 min per bed position; one to two bed posi-
tions from the diaphragm downwards to cover the entire liver;
image reconstruction by three-dimensional ordered subset expec-
tation maximization (3D-OSEM) algorithm incorporating time-
of-flight and point spread function information; 3 iterations and
18 subsets (4).
IMAGE ASSESSMENT TECHNIQUE
To provide the reader with a rational basis for each diag-
nosis of non-target activity, all presented cases are correlated
to angiography and further supported by 90Y bremsstrahlung
single-photon emission computed tomography with integrated
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FIGURE 1 | Large hepatocellular carcinoma of the right lobe (actual
tumor not well depicted). (A) Catheter-directed CT angiogram of the right
hepatic artery, proximal to the origin of the middle hepatic artery, delineates
the target arterial territory. (B) Digital subtraction angiography (DSA) of the
proper hepatic artery demonstrates the hepatic arterial tree. The liver is
supplied by the left hepatic artery (“L”; branch of the common hepatic
artery), middle hepatic artery (“M”; branch of the right hepatic artery) and
right hepatic artery (“R”; continuation of the common hepatic artery).
Prophylactic coil embolization of the gastroduodenal, right gastric, and
accessory left gastric arteries were performed. (C) DSA of the target arterial
tree with the catheter tip in the right hepatic artery, proximal to the origin of
the middle hepatic artery, immediately prior to RE. (D) Moderate vascular
stasis and contrast reflux into the left and proper hepatic arteries is seen on
DSA immediately after RE, with no change in catheter tip position. (E,F) 90Y
PET/CT depicts in high resolution, non-target activity in a non-random
distribution conforming to the anatomy of the untargeted left liver lobe
(arrows). (G,H) 90Y bremsstrahlung SPECT/CT shows concordant but subtle
diffuse non-target activity in the untargeted left liver lobe (arrows).
computed tomography (SPECT/CT) or technetium-99m (99mTc)
macroaggregated albumin (MAA) SPECT/CT.
Our image assessment technique for non-target activity detec-
tion centers on continuity-of-care and a thorough understanding
of case-specific angiography, in close collaboration with interven-
tional radiologists. These two components are paramount as they
provide the relevant clinical, angiographic, and dosimetric context
to the observed 90Y biodistribution and focus the operator onto
case-specific regions-at-risk (4).
FIGURE 2 | (A) Multifocal hepatocellular carcinoma with predominantly left
lobe disease seen on non-contrast-enhanced CT. The patient was recently
treated with sorafenib, a multi-kinase inhibitor with anti-angiogenic
properties. RE was performed in two injections via the left and right hepatic
arteries. Prophylactic coil embolization of the gastroduodenal artery was
not performed at the discretion of the interventional radiologist. (B) Digital
subtraction angiogram immediately after completion of right hepatic artery
RE with the catheter tip (“C”) in the right hepatic artery demonstrates
significant vascular stasis and reflux of contrast into the left hepatic
(“LHA”), proper hepatic, gastroduodenal (“GDA”), right gastroepiploic
(“RGE”), common hepatic and splenic (“S”) arteries. (C,D) 90Y PET/CT
depicts in high resolution, non-target activity in a non-random distribution
conforming to the anatomy of the lower anterior gastric wall. (E,F) 90Y
bremsstrahlung SPECT/CT shows concordant but subtle diffuse
bremsstrahlung activity along the lower anterior gastric wall. The
unexpected vascular stasis was attributed to reduced vascular capacitance
due to the anti-angiogenic effects of recent sorafenib therapy.
Firstly, the operator should actively adjust the upper PET visual
display threshold setting to deliberately increase the background
noise to moderate levels. This counter-intuitive action is necessary
because non-target activity is often of lower visual intensity than
noise spikes (4). If the upper PET visual display threshold had
remained at the settings used to suppress the background noise
for target activity assessment, it will be unlikely for the operator
to detect visually subtle, trace non-target activity. The lower PET
visual display threshold setting is 0 kBq/ml (4).
Next, the operator should carefully inspect the rotating maxi-
mum intensity projection (MIP) image for any activity protruding
from the regular outline of targeted tissue in a non-random pat-
tern, amidst background noise. Finally, the PET and PET/CT
images are reviewed in trans-axial, coronal, and saggital planes.
Non-target activity is characterized by a non-random pattern of
activity localizing to an untargeted anatomical structure on CT. A
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FIGURE 3 | (A) Recurrent cholangiocarcinoma at the surgical margin of a
previous left hemi-hepatectomy, seen on catheter-directed CT hepatic
angiogram of the right hepatic artery. RE was performed with the catheter
tip in the right hepatic artery, beyond the origin of the gastroduodenal
artery. Prophylactic coil embolization of the gastroduodenal artery was not
performed at the discretion of the interventional radiologist. (B) Post-RE
digital subtraction angiogram with the catheter tip (“C”) position
unchanged demonstrates significant vascular stasis and reflux of contrast in
the common hepatic, gastroduodenal (“GDA”), and right gastroepiploic
(“RGE”) arteries. (C,D,G,H) 90Y PET/CT in trans-axial and saggital planes
depict in high resolution, non-target activity in a non-random distribution
conforming to the anatomy of the gastric greater curve. (E,F,I,J) 90Y
bremsstrahlung SPECT/CT shows concordant but less intense and diffuse
non-target gastric activity.
qualitative diagnosis of non-target activity on 90Y PET/CT should
be based on its pattern and whether it conforms to underlying
anatomy, not by its visual intensity (4). The presence of a plausible
vascular etiology will greatly support a 90Y PET/CT diagnosis of
non-target activity, although this is not strictly essential because a
culprit vessel may not always be identified.
It is not essential to consider the presence or absence of cor-
relative clinical signs or symptoms when making a diagnosis of
non-target activity because clinical sequelae is a quantitative func-
tion of dose–response radiobiology over time, with no bearing
on the qualitative presence of non-target activity at the time of
scan. Similarly, it may sometimes be difficult to qualitatively distin-
guish noise spikes from genuine non-target activity. However, such
FIGURE 4 | (A) Hepatocellular carcinoma of the right lobe (“T”) in a
background of polycystic kidney and liver disease, seen on
non-contrast-enhanced CT. (B) RE was performed with the catheter tip
(“C”) in the right hepatic artery, proximal to the origin of the cystic artery
(“CA”), seen here on digital subtraction angiography (C,D) Catheter-directed
CT hepatic angiogram of the right hepatic artery demonstrates prominent
contrast enhancement of the gallbladder wall (“GB”).
FIGURE 5 | (A–F) 90Y PET/CT depicts in high resolution, non-target activity
in a non-random distribution conforming to the anatomy of the gallbladder
wall (arrows), shown here in trans-axial, coronal, and saggital planes,
respectively. (G–L) 90Y bremsstrahlung SPECT/CT shows concordant but
subtle diffuse non-target gallbladder activity.
indeterminate foci are usually too mild to result in any clinically
relevant toxicity even if genuine, and therefore do not often impact
post-RE management.
Parts of extra-hepatic viscera, which are closely adjacent to
the liver (e.g., gallbladder fundus, gastric lesser curve, pylorus,
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FIGURE 6 | (A) Multifocal hepatocellular carcinoma with a large segment III
tumor. Catheter-directed CT hepatic angiogram of the right internal
mammary artery (RIMA) demonstrates blood supply to one-third of the
large segment III tumor (“T”). (B) Digital subtraction angiogram (DSA) of
the RIMA demonstrates the target arterial tree, with three major branches
supplying the right lower anterior chest wall (“CW”) and a terminal branch
supplying tumor (“T”). The tumor blush is seen distally. The catheter tip was
positioned at the proximal RIMA (“C1”) for 99mTc MAA injection. (C)To
minimize non-target flow of 90Y resin microspheres to the chest wall, the
catheter tip was advanced to the origin of two chest wall arteries (“C2”),
where prophylactic bland embolization with gel foam slurry was performed
until vascular stasis; coil embolization at this position was technically not
possible due to vessel tortuosity. (D)The catheter tip was then pulled back
slightly (“C3”), proximal to the origin of the tumor branch (“T”). RE was
performed at this position with intermittent checks by DSA to ensure good
forward flow and no reflux of contrast.
proximal duodenum) are often anatomically inseparable from the
liver, making non-target activity detection in these areas very
challenging. This problem is further compounded by varying
degrees of PET/CT mis-registration due to the relatively long 90Y
PET acquisition time. However, these issues similarly affect 90Y
bremsstrahlung SPECT/CT and hence should not be viewed as a
comparative disadvantage.
Knowledge of the non-target absorbed dose may guide appro-
priate mitigative action to minimize non-target radiation toxicity.
Hence the detection of non-target activity should immediately
be followed by an assessment of the risk of developing clinically
significant radiation toxicity. This should be based on 90Y PET
quantification of the non-target absorbed dose, except in cases
of visually subtle, trace non-target activity where the absorbed
doses are unlikely to be clinically relevant. The topic of non-target
absorbed dose quantification by 90Y PET and tissue dose–response
is discussed elsewhere (5).
CASE EXAMPLES
The six case examples presented here were selected from a
23-patient cohort of predominantly hepatocellular carcinoma
patients treated with 90Y resin microsphere RE, described in detail
elsewhere (4). Of these 23 patients, 8 (34.8%) were detected to
have non-target activity by 90Y PET/CT. Untargeted liver was the
FIGURE 7 | (A,B) 90Y PET/CT depicts in high resolution, non-target activity
in a non-random distribution conforming to the anatomy of the right lower
anterior chest wall (white and red arrows). (C,D) Pre-RE 99mTc MAA
SPECT/CT shows similar non-target activity along the right lower anterior
chest wall (red arrows). The non-target chest wall activity on 90Y PET
depicted by white arrows was not seen on 99mTc MAA SPECT/CT due to
altered arterial flow and biodistribution after prophylactic bland embolization
of at-risk chest wall branches. (E,F) 90Y bremsstrahlung SPECT/CT was
unable to detect any non-target activity along the right lower anterior chest
wall due to its low image resolution.
most common site of non-target activity (3/8); only one example
is presented here for illustrative purposes. The other five cases of
non-target activity involve the stomach (2/8), gallbladder (1/8),
chest wall (1/8), and kidney (1/8). The non-target findings on
90Y PET/CT were conclusive in all cases. There were no cases of
undetected clinically significant non-target activity based on a ret-
rospective review of medical records at a median follow-up of
5.4 months (4).
Case 1: untargeted liver (Figure 1)
Case 2: stomach (Figure 2)
Case 3: stomach (Figure 3)
Case 4: gallbladder (Figures 4 and 5)
Case 5: chest wall (Figures 6 and 7)
Case 6: kidney (Figure 8)
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FIGURE 8 | Radioembolization to a site other than the liver. Bulky right
adrenal metastasis from chemorefractory gastrointestinal stromal tumor.
(A) Catheter-directed CT angiography of the right inferior adrenal artery
delineates the tumor (arrows) and the target arterial territory. (B) Digital
subtraction angiogram (DSA) immediately prior to microsphere injection
with the catheter tip (arrow) deep within the right inferior adrenal artery
demonstrates good forward flow of contrast toward the tumor. (C) Post-RE
DSA with no change to catheter tip (arrow) position demonstrates
significant vascular stasis and reflux of contrast down the right inferior
adrenal artery and distally into the terminal branches of the right renal
artery. The renal cortex (curved dashed line) of the right kidney (“K”) can be
seen. (D,E) 90Y PET/CT depicts in high resolution, non-target activity in a
non-random distribution conforming to the anatomy of the right renal cortex
(arrows). (F,G) 90Y bremsstrahlung SPECT/CT shows concordant but subtle
diffuse non-target activity in the right renal cortex.
Figure 9: the importance of deliberately increasing the back-
ground noise for non-target activity detection.
CONCLUDING REMARKS
With proper technique, the presence of background noise did not
pose a problem for qualitative assessment of non-target activ-
ity by 90Y PET/CT. The image resolution of non-target activity
by 90Y PET/CT was consistently superior to 90Y bremsstrahlung
SPECT/CT in all cases.
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FIGURE 9 |Three examples to highlight the importance of deliberately
increasing the background noise for non-target activity detection.
(A,D,G)These are duplicates of Figures 2D, 7B, and 8E, which show
non-target activity in the lower anterior gastric wall, right lower anterior
chest wall, and right renal cortex respectively, depicted with background
noise deliberately increased. (B,E,H) If the PET visual display threshold had
remained at the settings used for target activity assessment, the non-target
activity will appear subtle on PET and undetectable on PET/CT (C,F).
(I) Right renal cortex non-target activity is barely detectable on PET/CT.
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